Zydus Lifesciences Limited

NSE:ZYDUSLIFE.NS

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

🏬 Consumer Packaged Goods

🧴 Personal Care

💊 Pharmaceuticals

💉 Vaccines

Location

India

Market Cap

USD 10.98 B

Share Price

USD 10.90

Avg Daily Volume

972,862

Change (1 day)

-0.04%

Change (1 year)

-22.17%

Change (YTD)

-3.97%

Zydus Lifesciences Limited Operating Cash Flow for the year ending March 31, 2025: USD 793.01 M

Zydus Lifesciences Limited Operating Cash Flow is USD 793.01 M for the year ending March 31, 2025, a 104.92% change year over year. Operating cash flow is cash generated from the company’s regular business operations.

Zydus Lifesciences Limited Operating Cash Flow for the year ending March 31, 2024 was USD 386.99 M, a 18.29% change year over year.
Zydus Lifesciences Limited Operating Cash Flow for the year ending March 31, 2023 was USD 327.15 M, a 18.06% change year over year.
Zydus Lifesciences Limited Operating Cash Flow for the year ending March 31, 2022 was USD 277.11 M, a -38.38% change year over year.
Zydus Lifesciences Limited Operating Cash Flow for the year ending March 31, 2021 was USD 449.73 M, a 35.27% change year over year.